• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone.

作者信息

Brito-Babapulle F, Catovsky D, Newland A C, Goldman J M, Galton D A

出版信息

Semin Oncol. 1987 Jun;14(2 Suppl 1):51-2.

PMID:3473682
Abstract
摘要

相似文献

1
Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone.用中剂量阿糖胞苷和米托蒽醌治疗急性髓系白血病。
Semin Oncol. 1987 Jun;14(2 Suppl 1):51-2.
2
[Recurrence or therapeutic resistance of acute myelogenous leukemia. Effect of mitoxantrone and cytosine arabinoside].[急性髓性白血病的复发或治疗抵抗。米托蒽醌和阿糖胞苷的作用]
Tidsskr Nor Laegeforen. 1989 Jun 30;109(19-21):2004-6.
3
Mitoxantrone and standard dose cytosine arabinoside therapy in refractory or relapsed acute leukemia.米托蒽醌与标准剂量阿糖胞苷治疗难治性或复发性急性白血病。
Acta Haematol. 1994;92(1):14-7. doi: 10.1159/000204130.
4
High-dose cytosine arabinoside and mitoxantrone in high-risk acute nonlymphoblastic leukemia.大剂量阿糖胞苷与米托蒽醌治疗高危急性非淋巴细胞白血病
Semin Oncol. 1987 Jun;14(2 Suppl 1):18-20.
5
High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.大剂量阿糖胞苷联合米托蒽醌治疗难治性急性髓系白血病和急性淋巴细胞白血病
Semin Oncol. 1987 Jun;14(2 Suppl 1):73-7.
6
Phase I/II trial of high-dose cytosine arabinoside and mitoxantrone in adult refractory acute myeloid leukemia.
Haematol Blood Transfus. 1987;30:336-8. doi: 10.1007/978-3-642-71213-5_53.
7
High-dose versus intermediate-dose cytarabine combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age-adjusted randomized comparison.大剂量与中剂量阿糖胞苷联合米托蒽醌治疗复发难治性急性髓系白血病：一项年龄校正随机对照研究结果
Semin Hematol. 1991 Jul;28(3 Suppl 4):35-8.
8
Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.米托蒽醌与阿糖胞苷治疗成人急性白血病：中期报告
J Chemother. 1989 Jul;1(4 Suppl):1268-70.
9
Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.序贯标准剂量米托蒽醌和阿糖胞苷用于新诊断的成人急性髓细胞白血病
Neoplasma. 1999;46(1):61-5.
10
Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia.
Haematologica. 2000 Jul;85(7):769-70.

引用本文的文献

1
Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.急性髓系白血病的传统化疗：巴西的经验。
Sao Paulo Med J. 2000 Nov 9;118(6):173-8. doi: 10.1590/s1516-31802000000600005.
2
Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia.米托蒽醌：其药理特性及在急性非淋巴细胞白血病中的应用综述
Drugs Aging. 1996 Aug;9(2):122-47. doi: 10.2165/00002512-199609020-00007.
3
Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy.
米托蒽醌掺入单层脂质体的特性评估及其药代动力学性质、急性毒性和抗肿瘤疗效分析。
Cancer Chemother Pharmacol. 1991;27(6):429-39. doi: 10.1007/BF00685156.
4
High-dose ara-C and etoposide in refractory or relapsing acute leukemia.大剂量阿糖胞苷和依托泊苷用于难治性或复发性急性白血病
Cancer Chemother Pharmacol. 1991;28(6):487-90. doi: 10.1007/BF00685829.
5
Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia.高危复发或难治性急性髓系白血病中五天4'-（9-吖啶基氨基）甲磺酰间甲氧基苯胺与中剂量阿糖胞苷联合治疗
J Cancer Res Clin Oncol. 1991;117(5):489-92. doi: 10.1007/BF01612772.
6
Prognostic significance of cytochemical analysis of leukemic M2 blasts.白血病M2原始细胞的细胞化学分析的预后意义
Med Oncol Tumor Pharmacother. 1992;9(1):41-5. doi: 10.1007/BF02989652.